The Kerrisdale Capital Management LLC’s Chief Investment Officer and founder, Sahm Adrangi, was born in 1981. Mr. Sahm Adrangi graduated with a bachelor’s degree in Economics from Yale University in 2003. He has served in various positions in Deutsche Bank and Channin Capital partners. In the year 2009, he founded the Kerrisdale Capital Management LLC.
Mr. Adrangi started his career in April 2004, as an Analyst in Deutsche Bank where he helped syndicate and structure the bank’s high yield bonds and non-investment grade debt. Later, in December 2005, he worked as Analyst with Channin Capital Partners in the bankruptcy restructuring team where he advised creditors outside and inside court. He then joined Longacre Fund Management as an Investment Analyst.
As the founder of Kerrisdale Capital Management LLC, he has participated in several aspects of its expansion and development. Kerrisdale Capital Management LLC, recently rated at $150 was launched while under $1 million and is famous for publishing and selling research. In 2010, Mr. Andrangi gained fame when he named fraudulent Chinese companies like China-Botics and Lihua Education Alliance.
Sahm Adrangi developed an interest in the biotechnology sector and shared most of his researches about this field and focus on a variety of industries and companies. In the biotechnology sector, he has published researches on companies like Sage Therapeutics, Unilife, Bavarian Nordic and Pulse Biosciences. He has also published his researches on the market valuations and mining prospects. Apart from the publications, he is an active investor. Sahm Adrangi worked with Lindsay Corporation in developing capital allocation policies and cash deployment. He has also been a speaker at numerous conferences such as the value Investing conference and the Sohn Conference. He has been in interviews on Bloomberg and CNBC where he further illustrated his focus in research. Adrangi’s publications can be found on the New York Times and the Wall Street Journal.